<--- Back to Details
First PageDocument Content
Breakthrough therapy / Chemistry / Pharmaceutical sciences / Carbamates / Pharmacology / Pyrrolidines / Ombitasvir/paritaprevir/ritonavir / Ritonavir / Ombitasvir / AbbVie Inc. / Paritaprevir / Kidney
Date: 2016-08-04 23:27:20
Breakthrough therapy
Chemistry
Pharmaceutical sciences
Carbamates
Pharmacology
Pyrrolidines
Ombitasvir/paritaprevir/ritonavir
Ritonavir
Ombitasvir
AbbVie Inc.
Paritaprevir
Kidney

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Add to Reading List

Source URL: www.pmda.go.jp

Download Document from Source Website

File Size: 95,95 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells  Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document